RECENT ADVANCES IN PHARMACOLOGICAL STUDY OF NATURAL ANTICANCER AGENTS IN CHINA

被引:10
作者
XU, B
机构
[1] Shangai Institute of Materia Medica, Chinese Academy of Sciences.
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 1991年 / 86卷
关键词
ANTICANCER AGENTS; HYDROXYCAMPTOTHECIN; HOMOHARRINGTONINE; LYCOBETAINE; OXALYSINE;
D O I
10.1590/S0074-02761991000600014
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
In this paper a number of anticancer agents of natural origin will be presented. Hydroxycamptothecin (HCPT) was found to produce a strong inhibitory action on a variety of animal tumors. It is also effective for treatment of patients with gastric carcinoma, liver carcinoma, tumor of head and neck or leukemia. Pharmacologic studies showed that it could depress S phase of tumor cells significantly and cause formation of cellular chromatid breaks. By means of alkaline elution and nick translation methods it has been proved that HCPT induced DNA single strand breaks remarkably. Homoharringtonine (HHRT) was shown to be effective against acute leukemia. Recent experiments in tumor-bearing mice indicated that (HHRT) could diminish tumor metastasis. Using molecular hybridization technique it was demonstrated that (HHRT) decreased the content of c-myc RNA in the cytoplasm but not in the nuclei. Lycobetaine (LBT) possessed strong inhibitory effects on a number of ascites tumors. In clinical trials it was effective against ovarian and gastric carcinomas. It is able to intercalate into DNA. Oxalysine (OXL) is a new antibiotic and shown to be effective against tumor metastatis. When used in combination with 5-FU, its anticancer action could be enhanced. Other natural compounds such as indirubin, beta-elemene, irisquinone, oridonine, norcantharidin and PSP have been also found to possess antitumor action.
引用
收藏
页码:51 / 54
页数:4
相关论文
共 50 条
  • [31] Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents
    Hanikoglu, Aysegul
    Hanikoglu, Ferhat
    Ozben, Tomris
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2018, 19 (03) : 333 - 340
  • [32] Recent Progress of Adenosine Receptor Modulators in the Development of Anticancer Chemotherapeutic Agents
    Marwein, Sarapynbiang
    Mishra, Bijayashree
    De, Utpal C.
    Acharya, Pratap C.
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (26) : 2842 - 2858
  • [33] Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents
    Seddigi, Zaki S.
    Malik, M. Shaheer
    Saraswati, A. Prasanth
    Ahmed, Saleh A.
    Babalghith, Ahmed O.
    Lamfon, Hawazen A.
    Kamal, Ahmed
    MEDCHEMCOMM, 2017, 8 (08) : 1592 - 1603
  • [34] Recent advances in the chemistry of iron-based chemotherapeutic agents
    Basu, Uttara
    Roy, Mithun
    Chakravarty, Akhil R.
    COORDINATION CHEMISTRY REVIEWS, 2020, 417
  • [35] Discovery and development of natural product oridonin-inspired anticancer agents
    Ding, Ye
    Ding, Chunyong
    Ye, Na
    Liu, Zhiqing
    Wold, Eric A.
    Chen, Haiying
    Wild, Christopher
    Shen, Qiang
    Zhou, Jia
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 122 : 102 - 117
  • [36] The Recent Development of Tetrahydro-Quinoline/Isoquinoline Based Compounds as Anticancer Agents
    Yadav, Pratik
    Kumar, Ashish
    Althagafi, Ismail
    Nemaysh, Vishal
    Rai, Reeta
    Pratap, Ramendra
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2021, 21 (17) : 1587 - 1622
  • [37] Natural Alkaloids and Heterocycles as G-Quadruplex Ligands and Potential Anticancer Agents
    Che, Tong
    Wang, Yu-Qing
    Huang, Zhou-Li
    Tan, Jia-Heng
    Huang, Zhi-Shu
    Chen, Shuo-Bin
    MOLECULES, 2018, 23 (02):
  • [38] Recent Developments of DNA Poisons - Human DNA Topoisomerase IIα Inhibitors - as Anticancer Agents
    Pogorelnik, Barbara
    Perdih, Andrej
    Solmajer, Tom
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (13) : 2474 - 2488
  • [39] Enhancement of the efficacy of synthetic and natural anticancer agents through nanocarrier for colon cancer treatment
    Mukherjee, Kaushik
    Dutta, Pallobi
    Dey, Sourav
    Giri, Tapan Kumar
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2024, 10
  • [40] Recent Design and Structure-Activity Relationship Studies on the Modifications of DHFR Inhibitors as Anticancer Agents
    Wrobel, Agnieszka
    Drozdowska, Danuta
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (05) : 910 - 939